Diagnostic Imaging May Increase Testicular Cancer Risk
|
By MedImaging International staff writers Posted on 23 Nov 2020 |
Repeated exposures to diagnostic imaging, such as X-rays and computerized tomography (CT) scans, may increase the risk of testicular germ cell tumor (TGCT), according to a new study.
Researchers at the University of Pennsylvania (Penn; Philadelphia, USA), the Lee Moffitt Cancer Center and Research Institute (Tampa, FL, USA), and other institutions conducted a case-control study of 315 men with and 931 men without TGCT, recruited from hospital- and population-based settings. Study participants reported on exposures to x-ray or CT below the waist and lower gastrointestinal (GI) series or barium enema, which include a series of x-rays of the colon. Adjusted risk of TGCT was then calculated according to number of exposures and age at first exposure.
The results revealed that after adjustment for known risks of testicular cancer, including cryptorchidism and family history, race, age, and other factors, there was a statistically significant increased risk (59%) of TGCT among those reporting at least three exposures to X-ray, including a colon X-ray, and CT below the waist, compared to men with no such exposure. TGCT risk was also elevated for those exposed to diagnostic radiation during the first decade of their life, compared to those first exposed at age 18 years or older. The study was published on November 11, 2020, in PLOS One.
“The steady rise in TGCT cases over the past three or four decades suggests there is an environmental exposure risk at play, but no definitive risk factor has ever been identified,” said senior author Professor Katherine Nathanson, MD, of Penn. “Our data suggests that the increased use of diagnostic radiation below the waist in men over that same time may contribute to the increase in incidence. If our results are validated, efforts to reduce medically unnecessary and avoidable testicular exposure should be considered.”
TGCT is the most common cancer in white men aged 15–44 years of age, and incidence has increased rapidly in recent decades, particularly among those of European ancestry. Although multiple hypotheses investigating the impact of environmental exposures on risk of TGCT have been proposed, few were found to be robustly associated with the increasing incidence. One factor contributing to the rise in TGCT incidence may be the 20-fold increased use of diagnostic radiation in recent decades.
Related Links:
University of Pennsylvania
Lee Moffitt Cancer Center and Research Institute
Researchers at the University of Pennsylvania (Penn; Philadelphia, USA), the Lee Moffitt Cancer Center and Research Institute (Tampa, FL, USA), and other institutions conducted a case-control study of 315 men with and 931 men without TGCT, recruited from hospital- and population-based settings. Study participants reported on exposures to x-ray or CT below the waist and lower gastrointestinal (GI) series or barium enema, which include a series of x-rays of the colon. Adjusted risk of TGCT was then calculated according to number of exposures and age at first exposure.
The results revealed that after adjustment for known risks of testicular cancer, including cryptorchidism and family history, race, age, and other factors, there was a statistically significant increased risk (59%) of TGCT among those reporting at least three exposures to X-ray, including a colon X-ray, and CT below the waist, compared to men with no such exposure. TGCT risk was also elevated for those exposed to diagnostic radiation during the first decade of their life, compared to those first exposed at age 18 years or older. The study was published on November 11, 2020, in PLOS One.
“The steady rise in TGCT cases over the past three or four decades suggests there is an environmental exposure risk at play, but no definitive risk factor has ever been identified,” said senior author Professor Katherine Nathanson, MD, of Penn. “Our data suggests that the increased use of diagnostic radiation below the waist in men over that same time may contribute to the increase in incidence. If our results are validated, efforts to reduce medically unnecessary and avoidable testicular exposure should be considered.”
TGCT is the most common cancer in white men aged 15–44 years of age, and incidence has increased rapidly in recent decades, particularly among those of European ancestry. Although multiple hypotheses investigating the impact of environmental exposures on risk of TGCT have been proposed, few were found to be robustly associated with the increasing incidence. One factor contributing to the rise in TGCT incidence may be the 20-fold increased use of diagnostic radiation in recent decades.
Related Links:
University of Pennsylvania
Lee Moffitt Cancer Center and Research Institute
Latest Radiography News
- New Contrast Agent Enables Low-Dose X-Ray Joint Imaging
- AI Boosts Breast Cancer Detection and Cuts Screening Workload
- AI Tool Predicts Breast Cancer Risk Years Ahead Using Routine Mammograms
- Routine Mammograms Could Predict Future Cardiovascular Disease in Women
- AI Detects Early Signs of Aging from Chest X-Rays
- X-Ray Breakthrough Captures Three Image-Contrast Types in Single Shot
- AI Generates Future Knee X-Rays to Predict Osteoarthritis Progression Risk
- AI Algorithm Uses Mammograms to Accurately Predict Cardiovascular Risk in Women
- AI Hybrid Strategy Improves Mammogram Interpretation
- AI Technology Predicts Personalized Five-Year Risk of Developing Breast Cancer
- RSNA AI Challenge Models Can Independently Interpret Mammograms
- New Technique Combines X-Ray Imaging and Radar for Safer Cancer Diagnosis
- New AI Tool Helps Doctors Read Chest X‑Rays Better
- Wearable X-Ray Imaging Detecting Fabric to Provide On-The-Go Diagnostic Scanning
- AI Helps Radiologists Spot More Lesions in Mammograms
- AI Detects Fatty Liver Disease from Chest X-Rays
Channels
MRI
view channel
MRI Tool Enables Long-Term Tracking of Transplanted Cardiac Cells
Cell therapies for myocardial injury face a persistent hurdle: clinicians cannot easily monitor whether transplanted cells survive and where they persist in the heart. This limits optimization of dosing,... Read more
MRI-Based AI Tool Supports Differentiation of Parkinsonian Syndromes
Clinicians often struggle to differentiate Parkinsonian syndromes at initial presentation, when symptom overlap can obscure disease trajectory and delay targeted care. Imaging markers derived from diffusion... Read more
MRI-Derived Biomarker Improves Risk Stratification in Glioblastoma
Glioblastoma is marked by rapid growth and diffuse infiltration that complicate prognosis and treatment planning. Clinicians need objective tools that capture both how these tumors expand and how they... Read more
Combined Imaging Approach Identifies Cause of Heart Attack without Coronary Blockage
Patients who present with myocardial infarction but show no obstructive coronary disease often leave without a definitive diagnosis. That uncertainty complicates in-hospital decision-making and post-discharge... Read moreUltrasound
view channel
New Ultrasound AI Tool Supports Rapid Prenatal Assessment
Accurate gestational age estimation guides prenatal screening, detection of complications, and timely intervention. Access to ultrasound and trained sonographers is uneven, with nearly half of U.... Read more
New Consensus Standardizes Ultrasound-Based Fatty Liver Assessment
Metabolic dysfunction-associated steatotic liver disease (MASLD) is rising along with obesity and diabetes, making accurate, scalable measurement of hepatic fat a clinical priority. Biopsy is invasive... Read moreNuclear Medicine
view channel
PET Tracer Enables Noninvasive Measurement of Beta Cell Mass
Type 1 diabetes is an autoimmune disease in which the immune system destroys insulin-producing pancreatic beta cells. Loss of these cells destabilizes glucose control and drives complications.... Read more
New Imaging Tool Sheds Light on Tumor Fat Metabolism
Rapidly growing tumors reprogram metabolism to meet high energy demands. While many cancers preferentially consume glucose, lipid utilization by malignant cells is difficult to measure in living subjects.... Read more
Radiopharmaceutical Molecule Marker to Improve Choice of Bladder Cancer Therapies
Targeted cancer therapies only work when tumor cells express the specific molecular structures they are designed to attack. In urothelial carcinoma, a common form of bladder cancer, the cell surface protein... Read moreGeneral/Advanced Imaging
view channel
Hybrid AI System Improves Early Lung Cancer Detection on CT
Early lung cancer often presents as tiny nodules on computed tomography (CT) that are difficult to distinguish from normal tissue, leading to delayed diagnoses. Missed or late findings limit timely intervention... Read more
Radiomics Analysis of CT Scans Enhances Evaluation of Sarcoidosis
Sarcoidosis is a complex inflammatory lung disease that can cause scarring and breathing difficulties in more than 150,000 people in the United States. Clinicians often rely on visual review of chest computed... Read moreImaging IT
view channel
Breast Imaging Software Enhances Visualization and Tissue Characterization in Challenging Cases
Breast imaging can be particularly challenging in cases involving small breasts or implants, where image reconstruction and tissue characterization may be limited. Clinicians also need reproducible analysis... Read more
New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology
The global artificial intelligence (AI) in medical diagnostics market is expanding with early disease detection being one of its key applications and image recognition becoming a compelling consumer proposition... Read moreIndustry News
view channel
Nuclear Medicine Set for Continued Growth Driven by Demand for Precision Diagnostics
Clinical imaging services face rising demand for precise molecular diagnostics and targeted radiopharmaceutical therapy as cancer and chronic disease rates climb. A new market analysis projects rapid expansion... Read more







